Tuesday News
Warner Chilcott To Buy P&G’s Pharma Business
News from FDA, Parexel, PPD, Ligand Pharmaceuticals, D-Pharm and Orexigen.
The pace is glacial. But everything the pharmaceutical industry does is becoming more centralized, more standardized—and more electronic. Electrocardiograms (ECGs) are one example. Another is the computer-aided review of endpoints in clinical trials. Icon has been facilitating endpoint adjudication for as long as any firm in the industry, and we recently had a chance to check in with Rafael Escandon, consulting VP of clinical outcome services. Escandon works in the contract research organization's imaging group. The electronic, objective, independent assessment of images, he says, is an area of particular pride at Icon. But the firm's technology and services push has taken him and his clinical endpoint committee (CEC) colleagues far afield from imaging, and into a wide swath of other projects. Says Escandon: "This is a different core service. It's one we've built a dedicated team around." Underappreciated CEC That makes sense. After all, a CEC's blinded work precedes and aids…more...
Like those who work in quarries and mines, journalists covering the pharmaceutical industry wear special ear protection while on the job. It's all required by OSHA and has greatly advanced over…more...
It would be hard to find a firm handling more electrocardiogram (ECG) data than ERT. The company handles 9 million ECG data points annually. Not long ago, the firm decided to…more...
It’s easy to give a sharp salute to "quality." What modern research organization would oppose it? Quality refrigerators, quality cars, quality overnight packages can be defined easily. Quality in a clinical…more...
Editor's Note: Through association with certain spiritual mentalists and accredited acupuncturists, the editor of ClinPage has received what he has been assured is a bonafide transcript from nine years in the future. From the year 2019, to be precise. The transcript below purports to be the byproduct of a U.S. Freedom of Information Act (FOIA) request. It…more...
We asked Quintiles to tell us about one of the most improved sites or site networks in its five-year-old partner sites program. The contract research organization (CRO) introduced us to Piedmont Medical Research, a group of 11 sites in North Carolina, South Carolina and Tennessee. The network is based in Winston-Salem, N.C. It's comprised of nine sites…more...
The contract research organization (CRO) PPD unleashed enough news for a year this week. The company announced a long list of new directions, ominous numbers and strategic shifts, including: • The company's quarterly earnings (not great, but not terrible); • The planned acquisition of the Chinese CRO Excel PharmaStudies, which will make PPD a major player in…more...
The corporate parent of contract research organization (CRO) Chiltern bought MDS Pharma's central labs. Last week, private investment group Czura Thornton agreed to pay $8 million for the labs and an additional $4 million later if performance thresholds are met. The sale is part of Canadian conglomerate MDS Inc.'s continued selling of clinical assets, including MDS Pharma…more...
News from FDA, Parexel, PPD, Ligand Pharmaceuticals, D-Pharm and Orexigen.
Starting in a few weeks, FDA and EMEA will work together on GCP inspection issues. Their call to the sponsor community.
Why some CROs won’t say exactly how many feet they have on the ground in India.
In the first installment of our series on trials in India, we look at the upsides, downsides and numbers.
OneWorld explains how it delivers scientific excellence and low budgets in a nonprofit context.
The CRO discusses its instrument to assess gaps in drug safety risk assessment and mitigation.
Imaging CRO WorldCare gets a heavy-hitting CMO and beefs up its in-house system.
Organizations
Conferences
Info & Opinion
© 2012 ClinPage. All Rights Reserved.